JAMA Network Home
Sign In
Original Investigation

Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer

JAMA Internal Medicine 10.1001/jamainternmed.2026.4773

August 30, 2026 at 5:00 AM EDT

Read the full article

In this randomized clinical trial, routine referral of patients with prostate cancer to a cardiovascular specialist lead to improved outcomes, specifically through better cholesterol control. However, it is uncertain whether this reduced clinical cardiovascular events.

Improved cardiovascular risk management among patients with prostate cancer was driven largely by better cholesterol control and greater statin use.

Meeting Information: ESC 2026

This paper will be presented during European Society of Cardiology Congress in Munich, Germany.

Local Embargo Time: 11:00 A.M. CEST.

ESC Presentation: Darryl Leong will simultaneously present the findings during the late-breaking clinical science session on cardio-oncology in Ashgabat, Hall A3.

Corresponding Author: Darryl P. Leong, PhD, Population Health Research Institute, McMaster University and Hamilton Health Sciences, David Braley Building, 237 Barton St East, Hamilton, ON L8L 2X2, Canada (Darryl.leong@phri.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.4773?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083026

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks